No registrations found.
ID
Source
Brief title
Health condition
sleepingdisorder, slaapstoornissen
Sponsors and support
Intervention
Outcome measures
Primary outcome
Benzodiazepine use.
Secondary outcome
Outcomes related to the sleepingdisorder.
Background summary
Study the effects of short-term cognitive behavioral therapy (CBT) given by psychiatric nurse practitioners with familiar patients with chronic benzodiazepine use and new patients in the family practice with sleepingdisorders.
Study objective
Study the effects of short-term cognitive behavioral therapy (CBT) given by psychiatric nurse practitioners with familiar patients with chronic benzodiazepine use and new patients in the family practice with sleepingdisorders.
Study design
Benzodiazepine gebruik:
Extraction from Electronic Medical System (HIS) (2 times with 3 months interval).
Outcomes related to the sleepingdisorder (2 times with 3 months interval):
1. Pittsburgh Sleep Quality Index (19 items);
2. Insomnia Severity Index (7 items);
3. Self-Efficacy Scale (9 items);
4. Houding en gedachten ten opzichte van de slaap (16 items);
5. Therapy Evaluation Questionnaire (7 items: only interventiongroup);
6. Slaapwaakkalender (only interventiongroup);
7. Slaapevaluatieformulier (6 items: only interventiongroup).
Intervention
Interventiongroup:
Patients in the interventiongroup receive a letter with an invitation to make use of the cognitive behavioral therapy. This include 5 sessions with the POH GGZ en the use of a sleepdiary and a sleepevaluation questionnaire.
The control group receive usual care of sleepdisorders. They don't receive a letter with an invitation and don't get the option of cognitive behavioral therapy and the use of a sleeping diary and sleep evaluation questionnaire. They do complete two times 4 questionnaires (see below) with an interval of 3 months.
Postbus 9101, huispost 114
G. Ven, van de
IQ healthcare
Postbus 9101, huispost 114
Nijmegen 6500 HB
The Netherlands
+31 (0)243616796
G.vandeVen@iq.umcn.nl
Postbus 9101, huispost 114
G. Ven, van de
IQ healthcare
Postbus 9101, huispost 114
Nijmegen 6500 HB
The Netherlands
+31 (0)243616796
G.vandeVen@iq.umcn.nl
Inclusion criteria
1. Patients familiar with chronic benzodiazepine use;
2. New patients who come to the family practitioner with sleepingdisorders.
Exclusion criteria
1. Current psychiatric treatment;
2. Drug or alcohol dependency treatment;
3. Psychosis in medical history;
4. Epilepsy;
5. Terminal disease;
6. Not having mastered the Dutch language;
7. Individual family practitioners reasons
severe comorbidity;
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL1843 |
NTR-old | NTR1954 |
Other | Stichting Robuust : |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |